Submission of Audited Financial Results of Jhonson Pharmacare ltd for the quarter and year ended on March 31st March 2026
Pursuant to Regulation 30 of SEBI (LODR) Regulations 2015 there is change.
meeting of board of director to considered and approved the following 1.audited financial results 2. Statement of deviation or variation 3. take note on resignation of Rajendra prasad (Non- executive director) 4. take note on resignation of umesh kumar (executive director)
Annual secretarial compliance report for the F.Y 31ST MARCH 2026
Submission of Extract of Newspaper Publication of Audited (Standalone) Financial Results for the quarter and year ended on 31st March 2026
Undertaking for Non- Applicability of Regul;ation 32 of SEBI (LODR) Regulation 2015 for the quarter and financial year ended 31st March 2026
Submission of audited financial results for the quarter and financial year ended 3st March 2026
Submission of audited financial results for the quarter and financial year ended 3st March 2026
Pursuant to the provisions of Regulation 30 and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that the meeting of the Board of Directors of the Company was held today i.e., Wednesday 27th May, 2026 which commenced at 07:15 P.M. and concluded at 07:45 P.M. at the registered office of the company at Office No. 4-D, Fourth Floor Vardan Tower, Lakhudi Circle, Near Sardar Patel Stadium, Navrangpura, Ahmedabad City, Gujarat, India, 380009 have considered and approved the following: